Savitz Adam's Form 4 filing
Alto Neuroscience, Inc. (ANRO) · filed Jul 11, 2024
- Accession no.
- 0001415889-24-019488
- Filed
- Jul 11, 2024
- Trade date
- Jul 9-10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $190.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Savitz AdamCIK 0002008707 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2024 | Common Stock | PPurchaseAcquired | +10,681 | $12.53 | +$133,832.93 | 35,532 | Indirect | |
| Jul 9, 2024 | Common Stock | PPurchaseAcquired | +1,388 | $13.15 | +$18,252.2 | 36,920 | Indirect | |
| Jul 10, 2024 | Common Stock | PPurchaseAcquired | +2,931 | $13.22 | +$38,747.82 | 39,851 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.